Lung Carcinoma — Trials

Lung Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,130
Recruiting: 1,129
Ph III recruiting: 164
Growth YoY: +0.2%
Industry share: 43%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,179)

clinicaltrialsPublishedShowing 401–450 of 1,347 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05098132	Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers(SYNERGY-101)	recruiting	Phase 1 / Phase 2	364	SynthekineINDUSTRY	4	Jul 21, 2026	clinicaltrials
NCT06088771	Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC	recruiting	Phase 1 / Phase 2	21	Icahn School of Medicine at Mount SinaiOTHER	1	Jul 21, 2026